Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com initiated coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a research note issued to investors on Thursday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Performance Shares of EGRX stock opened at $1.30 on Thursday. The business’s 50 day moving […]
Investment analysts at StockNews.com initiated coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a research note issued to investors on Thursday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Performance Shares of EGRX stock opened at $1.30 on Thursday. The business’s 50 day moving […]
